Abstract

Lateral pelvic lymph node metastasis was an major cause of locoregional recurrence of mid-low rectal cancer. Although long-term benefit of routine lateral lymph node dissection has not been proved by randomized controlled trial, retrospective studies have shown its efficacy in lowering local recurrence and increasing survival rate in patients with lateral lymph node metastasis. Recently, laparoscopic total mesorectal excision surgery was performed in patients with advanced low rectal cancer, followed by selective unilateral or bilateral lateral lymph node dissection based on pretreatment imaging after preoperative chemoradiation. This technique is safe and feasible with favorable short-term results. We will discuss it in this paper. Key words: Mid-low rectal neoplasms; Total mesorectal excision; Neoadjuvant chemoradiation; Lateral pelvic lymph node metastasis; Laparoscopic lateral pelvic lymph node dissection

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.